Subliminal Laser
Therapy for Retinal
Disorders

How to treat retina today?

subliminal laser therapy treatment application

For a quarter of a century, laser photocoagulation has been considered a safe and effective treatment option for macular pathologies. Over the years, the development and introduction of new and innovative macular laser technologies has confirmed that, alongside intravitreal injections, photocoagulation laser therapy still plays a valuable role in the surgeons’ treatment armamentarium.

Today, ophthalmologists can offer their patients enhanced retinal treatment options, with greater safety and efficacy than ever before.

*Image courtesy of Alejandro Filloy Rius, MD, Ph.D. – Tarragona, Spain

retina image subliminal laser therapy treatment

Subliminal laser therapy:

Unlike conventional thermal laser, Subliminal laser therapy is a non-damaging treatment mode based on a train of microsecond pulses.

It involves a series of repetitive laser pulses with intervals (cooling times) and produces a therapeutic treatment effect without inducing scarring or RPE damage on clinical examination during or after treatment.

Its use is dedicated to the treatment of macular diseases.

  • A macular treatment
There remains an unmet need in the treatment of macular diseases. Increasing evidence demonstrates SubLiminal laser therapy to be safe and effective for macular conditions such as DME and CSC.
Learn more
Learn more

Several studies demonstrate that retinal destruction was required to control the neovascularization process in PDR. For peripheral conditions Multispot laser photocoagulation should be favored.

Learn more
Learn more

Easily access to our clinical database

Find our latest clinical data regarding subliminal laser therapy

LATEST CLINICAL DATA

Access a range of clinical educational content, to all the clinical content available about for both macula and peripheral treatments, including: clinical articles, clinical videos, treatment guidelines…
Dr Wu 2022 EURETINA
Play button

Subthreshold laser: a new hope for macular degeneration?

16/09/2022
Dr Lihteh Wu presents why Subthreshold laser can be consider as a new hope for macular degeneration.
View
Laser to Drusen in AMD

Laser to Drusen in AMD

13/02/2023
Laser photocoagulation can improve vision by promoting resorption of the drusen.
View
PIE SOLS symposium 2022 12 min

Experts Layout Guidelines for Subthreshold Laser Treatment

23/11/2022
Many countries are unable to afford continuous unending intravitreal injections for macular diseases,” said Dr. Kenneth Fong. Building the case for the use of subthreshold laser (STL) treatment and its application for retinal diseases, Dr. Fong and two other vitreoretinal doctors presented at a symposium on behalf of The Subthreshold Ophthalmic Laser Society (SOLS) at the recently held CAKE & PIE Expo 2.0 in Da Nang, Vietnam.
View
Subthreshold laser therapy guidelines for retinal diseases

Subthreshold laser therapy guidelines for retinal diseases

19/09/2022
Subthreshold laser therapy has been utilised in clinical practice for more than three decades, and numerous randomised and real-life studies has proven its efficacy and safety in various retinal diseases. However, despite decades of usage, we still do not have a standard protocol for subthreshold laser applications and settings.
View
CSC-verteporfin-min

Central Serous Chorioretinopathy: Can it be treated without Visudyne?

03/05/2022
Given the difficulty of obtaining verteporfin for chronic CSCR, it is worth considering subthreshold laser therapy as an alternative given its comparable efficacy and practical advantages. We know that the prognosis for this disease depends on the level of disease progression, so a therapeutic option that allows for an undelayed treatment is extremely interesting.
View
Laser to Drusen in AMD

Laser to Drusen in AMD

13/02/2023
Laser photocoagulation can improve vision by promoting resorption of the drusen.
View
PIE SOLS symposium 2022 12 min

Experts Layout Guidelines for Subthreshold Laser Treatment

23/11/2022
Many countries are unable to afford continuous unending intravitreal injections for macular diseases,” said Dr. Kenneth Fong. Building the case for the use of subthreshold laser (STL) treatment and its application for retinal diseases, Dr. Fong and two other vitreoretinal doctors presented at a symposium on behalf of The Subthreshold Ophthalmic Laser Society (SOLS) at the recently held CAKE & PIE Expo 2.0 in Da Nang, Vietnam.
View
Access to all our clinical data